API Portfolio

A wide range of high-quality Active Pharmaceutical Ingredients (APIs) are offered by Egis Pharmaceutical. Our API portfolio encompasses various therapeutic categories, ensuring that we cater to the diverse needs of the pharmaceutical industry.

Our Anti-malarial APIs are specifically designed to combat malaria, a prevalent and life-threatening disease. We offer a comprehensive range of APIs that target malaria-causing parasites, aiding in developing effective anti-malarial medications. Our Anti-malarial APIs undergo stringent quality control processes to ensure their purity, potency, and compliance with regulatory standards. By providing reliable and high-quality APIs, we contribute to global efforts in eradicating malaria and improving public health.

Cancer is a complex and challenging disease, and our Anti Cancer APIs play a pivotal role in the fight against it. We offer a diverse selection of APIs used in the development of anti-cancer medications. These APIs target specific cancer cells, inhibiting their growth and spread. Our Anti Cancer APIs are sourced from trusted manufacturers who prioritize quality and adhere to stringent industry standards. By supplying premium-quality APIs, we support the development of innovative therapies and treatments that improve patient outcomes and quality of life.

At Egis Pharmaceutical, we recognize the importance of animal health and well-being. Our Veterinary APIs cater to the unique pharmaceutical needs of the veterinary industry. These APIs are specifically formulated for animals, addressing various health conditions and promoting their overall wellness. We source Veterinary APIs from reputable suppliers known for their dedication to animal healthcare and stringent quality control processes. With our Veterinary APIs, we aim to support veterinarians and animal caregivers in providing optimal care to their animal patients.